Mechanism of action for metoprolol
Pro Research Analysisby 
Searched over 200M research papers
Mechanism of Action for Metoprolol
Beta-Adrenergic Receptor Antagonism
Metoprolol is a selective beta-1 adrenergic receptor antagonist, commonly known as a beta-blocker. It primarily inhibits the cardiac response to both exogenous and neuronally released norepinephrine, which is a key determinant of its hemodynamic effects . This selective inhibition reduces heart rate, myocardial contractility, and cardiac output, making it effective in treating conditions like hypertension and angina pectoris .
Cardiovascular Effects
Hypertension and Angina
Metoprolol is widely used to manage mild to moderate hypertension and angina pectoris. It achieves its therapeutic effects by dose titration within the therapeutic range, effectively reducing blood pressure and heart rate . The drug's beta-1 selectivity allows it to be administered to patients with conditions like asthma and diabetes, where non-selective beta-blockers are contraindicated .
Myocardial Infarction
In the context of myocardial infarction, metoprolol has been shown to reduce infarct size and improve survival rates, particularly in high-risk patients. This is achieved through its action on beta-1 adrenergic receptors in cardiomyocytes and its ability to inhibit neutrophil migration, thereby reducing inflammation and reperfusion injury .
Hemodynamic and Energetic Benefits
Dilated Cardiomyopathy
In patients with nonischemic dilated cardiomyopathy, metoprolol improves left ventricular performance and myocardial efficiency without increasing myocardial oxygen consumption. This suggests that the drug enhances myocardial energetics and alters substrate utilization, favoring carbohydrate over fatty acid metabolism .
Resistance Artery Function
However, metoprolol can impair resistance artery function by reducing vasodilation in response to beta-2 adrenergic agonists. This effect may contribute to increased systemic vascular resistance and reduced tissue oxygen delivery, which could explain the increased mortality observed with acute administration in certain patient populations .
Diuretic Effect
Metoprolol also exhibits a diuretic effect, significantly increasing urine output without altering serum sodium levels but increasing serum potassium levels. This effect is likely due to increased renal blood flow and glomerular filtration rate .
Electrophysiological Effects
Metoprolol has been characterized as a class II antiarrhythmic agent. It can affect cellular electrophysiological activity by decreasing the duration and voltage of the action potential plateau in cardiac cells. It also exhibits use-dependent inhibition of sodium channels and reduces peak inward rectifying potassium and L-type calcium currents, which may contribute to its antiarrhythmic properties .
Herb-Drug Interactions
The pharmacokinetics of metoprolol can be significantly altered by concurrent administration of other substances. For instance, Astragaloside IV (AST) has been shown to increase the plasma exposure of metoprolol by inhibiting its metabolism through the CYP2D6 enzyme, highlighting the potential for herb-drug interactions .
Conclusion
Metoprolol's mechanism of action is multifaceted, involving selective beta-1 adrenergic receptor antagonism, hemodynamic and energetic improvements, diuretic effects, and electrophysiological modulation. These combined actions make it a versatile drug in the management of cardiovascular diseases, although its effects on resistance artery function and potential for herb-drug interactions warrant careful consideration.
Sources and full results
Most relevant research papers on this topic